Fluorine in PDB 8fy6: Sars-Cov-2 Main Protease in Complex with Covalent Inhibitor
Enzymatic activity of Sars-Cov-2 Main Protease in Complex with Covalent Inhibitor
All present enzymatic activity of Sars-Cov-2 Main Protease in Complex with Covalent Inhibitor:
3.4.22.69;
Protein crystallography data
The structure of Sars-Cov-2 Main Protease in Complex with Covalent Inhibitor, PDB code: 8fy6
was solved by
W.Fried,
X.S.Chen,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
41.64 /
2.00
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
45.455,
63.276,
103.843,
90,
90,
90
|
R / Rfree (%)
|
18.7 /
22.2
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Sars-Cov-2 Main Protease in Complex with Covalent Inhibitor
(pdb code 8fy6). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the
Sars-Cov-2 Main Protease in Complex with Covalent Inhibitor, PDB code: 8fy6:
Jump to Fluorine binding site number:
1;
2;
3;
Fluorine binding site 1 out
of 3 in 8fy6
Go back to
Fluorine Binding Sites List in 8fy6
Fluorine binding site 1 out
of 3 in the Sars-Cov-2 Main Protease in Complex with Covalent Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Sars-Cov-2 Main Protease in Complex with Covalent Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:73.3
occ:1.00
|
F1
|
A:OW1401
|
0.0
|
73.3
|
1.0
|
C17
|
A:OW1401
|
1.4
|
53.8
|
1.0
|
F2
|
A:OW1401
|
2.2
|
52.6
|
1.0
|
F3
|
A:OW1401
|
2.2
|
66.1
|
1.0
|
C16
|
A:OW1401
|
2.4
|
44.9
|
1.0
|
O4
|
A:OW1401
|
2.6
|
43.2
|
1.0
|
HE3
|
A:MET165
|
2.7
|
62.5
|
1.0
|
HB2
|
A:GLN192
|
2.7
|
55.8
|
1.0
|
O
|
A:THR190
|
3.0
|
49.9
|
1.0
|
HE21
|
A:GLN192
|
3.1
|
50.0
|
1.0
|
HE1
|
A:MET165
|
3.1
|
62.5
|
1.0
|
CE
|
A:MET165
|
3.2
|
52.0
|
1.0
|
HE2
|
A:MET165
|
3.2
|
62.5
|
1.0
|
NE2
|
A:GLN192
|
3.4
|
41.6
|
1.0
|
HD13
|
A:LEU167
|
3.5
|
53.4
|
1.0
|
N4
|
A:OW1401
|
3.5
|
30.3
|
1.0
|
H
|
A:THR190
|
3.6
|
53.0
|
1.0
|
CB
|
A:GLN192
|
3.6
|
46.4
|
1.0
|
HG3
|
A:GLN192
|
3.7
|
53.8
|
1.0
|
H
|
A:GLN192
|
3.7
|
53.8
|
1.0
|
HE22
|
A:GLN192
|
3.8
|
50.0
|
1.0
|
H20
|
A:OW1401
|
3.8
|
36.5
|
1.0
|
CD
|
A:GLN192
|
3.8
|
46.4
|
1.0
|
CG
|
A:GLN192
|
3.9
|
44.8
|
1.0
|
O
|
A:ARG188
|
4.0
|
35.6
|
1.0
|
N
|
A:GLN192
|
4.1
|
44.8
|
1.0
|
HA
|
A:GLN189
|
4.2
|
44.2
|
1.0
|
C
|
A:THR190
|
4.2
|
48.8
|
1.0
|
HB3
|
A:GLN192
|
4.3
|
55.8
|
1.0
|
N
|
A:THR190
|
4.3
|
44.1
|
1.0
|
HD3
|
A:PRO168
|
4.3
|
65.9
|
1.0
|
CD1
|
A:LEU167
|
4.3
|
44.5
|
1.0
|
HA
|
A:LEU167
|
4.4
|
49.3
|
1.0
|
CA
|
A:GLN192
|
4.4
|
47.6
|
1.0
|
HD12
|
A:LEU167
|
4.5
|
53.4
|
1.0
|
HD11
|
A:LEU167
|
4.5
|
53.4
|
1.0
|
O
|
A:GLN192
|
4.5
|
53.4
|
1.0
|
O
|
A:GLU166
|
4.6
|
34.6
|
1.0
|
OE1
|
A:GLN192
|
4.7
|
39.9
|
1.0
|
C15
|
A:OW1401
|
4.8
|
39.5
|
1.0
|
H19
|
A:OW1401
|
4.8
|
47.5
|
1.0
|
HB2
|
A:MET165
|
4.8
|
43.6
|
1.0
|
C
|
A:GLN192
|
4.9
|
55.0
|
1.0
|
HG2
|
A:GLN192
|
4.9
|
53.8
|
1.0
|
SD
|
A:MET165
|
4.9
|
45.0
|
1.0
|
C
|
A:ALA191
|
4.9
|
47.4
|
1.0
|
HG22
|
A:THR190
|
4.9
|
57.1
|
1.0
|
CA
|
A:THR190
|
4.9
|
49.9
|
1.0
|
|
Fluorine binding site 2 out
of 3 in 8fy6
Go back to
Fluorine Binding Sites List in 8fy6
Fluorine binding site 2 out
of 3 in the Sars-Cov-2 Main Protease in Complex with Covalent Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Sars-Cov-2 Main Protease in Complex with Covalent Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:52.6
occ:1.00
|
F2
|
A:OW1401
|
0.0
|
52.6
|
1.0
|
C17
|
A:OW1401
|
1.4
|
53.8
|
1.0
|
F1
|
A:OW1401
|
2.2
|
73.3
|
1.0
|
F3
|
A:OW1401
|
2.2
|
66.1
|
1.0
|
C16
|
A:OW1401
|
2.4
|
44.9
|
1.0
|
HE3
|
A:MET165
|
2.4
|
62.5
|
1.0
|
H20
|
A:OW1401
|
2.4
|
36.5
|
1.0
|
HD13
|
A:LEU167
|
2.5
|
53.4
|
1.0
|
O
|
A:GLU166
|
2.5
|
34.6
|
1.0
|
HE2
|
A:MET165
|
2.5
|
62.5
|
1.0
|
N4
|
A:OW1401
|
2.7
|
30.3
|
1.0
|
HA
|
A:LEU167
|
2.8
|
49.3
|
1.0
|
CE
|
A:MET165
|
2.9
|
52.0
|
1.0
|
C
|
A:GLU166
|
3.3
|
38.2
|
1.0
|
O4
|
A:OW1401
|
3.4
|
43.2
|
1.0
|
HB2
|
A:MET165
|
3.4
|
43.6
|
1.0
|
CD1
|
A:LEU167
|
3.5
|
44.5
|
1.0
|
HE1
|
A:MET165
|
3.5
|
62.5
|
1.0
|
HG3
|
A:MET165
|
3.5
|
43.4
|
1.0
|
HD22
|
A:LEU167
|
3.5
|
55.3
|
1.0
|
CA
|
A:LEU167
|
3.6
|
41.1
|
1.0
|
HD3
|
A:PRO168
|
3.8
|
65.9
|
1.0
|
N
|
A:LEU167
|
3.8
|
38.4
|
1.0
|
HD11
|
A:LEU167
|
3.9
|
53.4
|
1.0
|
HD12
|
A:LEU167
|
3.9
|
53.4
|
1.0
|
HB2
|
A:GLN192
|
3.9
|
55.8
|
1.0
|
H
|
A:GLU166
|
4.0
|
37.9
|
1.0
|
CG
|
A:MET165
|
4.1
|
36.1
|
1.0
|
C15
|
A:OW1401
|
4.1
|
39.5
|
1.0
|
N
|
A:GLU166
|
4.2
|
31.6
|
1.0
|
CB
|
A:MET165
|
4.2
|
36.3
|
1.0
|
CG
|
A:LEU167
|
4.2
|
45.6
|
1.0
|
CD2
|
A:LEU167
|
4.3
|
46.0
|
1.0
|
SD
|
A:MET165
|
4.3
|
45.0
|
1.0
|
H28
|
A:OW1401
|
4.3
|
40.6
|
1.0
|
CA
|
A:GLU166
|
4.4
|
35.5
|
1.0
|
CB
|
A:LEU167
|
4.5
|
41.9
|
1.0
|
HD21
|
A:LEU167
|
4.5
|
55.3
|
1.0
|
O3
|
A:OW1401
|
4.5
|
35.7
|
1.0
|
C14
|
A:OW1401
|
4.6
|
35.0
|
1.0
|
H
|
A:LEU167
|
4.6
|
46.1
|
1.0
|
C
|
A:LEU167
|
4.6
|
41.8
|
1.0
|
H19
|
A:OW1401
|
4.6
|
47.5
|
1.0
|
CD
|
A:PRO168
|
4.7
|
54.9
|
1.0
|
H26
|
A:OW1401
|
4.8
|
42.5
|
1.0
|
HB3
|
A:MET165
|
4.8
|
43.6
|
1.0
|
CB
|
A:GLN192
|
4.9
|
46.4
|
1.0
|
C
|
A:MET165
|
4.9
|
33.2
|
1.0
|
HB3
|
A:LEU167
|
4.9
|
50.3
|
1.0
|
HE21
|
A:GLN192
|
4.9
|
50.0
|
1.0
|
HA
|
A:GLU166
|
5.0
|
42.6
|
1.0
|
N
|
A:PRO168
|
5.0
|
48.6
|
1.0
|
NE2
|
A:GLN192
|
5.0
|
41.6
|
1.0
|
O
|
A:GLN192
|
5.0
|
53.4
|
1.0
|
|
Fluorine binding site 3 out
of 3 in 8fy6
Go back to
Fluorine Binding Sites List in 8fy6
Fluorine binding site 3 out
of 3 in the Sars-Cov-2 Main Protease in Complex with Covalent Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Sars-Cov-2 Main Protease in Complex with Covalent Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F401
b:66.1
occ:1.00
|
F3
|
A:OW1401
|
0.0
|
66.1
|
1.0
|
C17
|
A:OW1401
|
1.4
|
53.8
|
1.0
|
F2
|
A:OW1401
|
2.2
|
52.6
|
1.0
|
F1
|
A:OW1401
|
2.2
|
73.3
|
1.0
|
C16
|
A:OW1401
|
2.4
|
44.9
|
1.0
|
HD3
|
A:PRO168
|
2.8
|
65.9
|
1.0
|
H20
|
A:OW1401
|
3.0
|
36.5
|
1.0
|
N4
|
A:OW1401
|
3.0
|
30.3
|
1.0
|
O4
|
A:OW1401
|
3.1
|
43.2
|
1.0
|
HA
|
A:LEU167
|
3.2
|
49.3
|
1.0
|
O
|
A:GLU166
|
3.4
|
34.6
|
1.0
|
HD13
|
A:LEU167
|
3.5
|
53.4
|
1.0
|
HG3
|
A:PRO168
|
3.7
|
64.5
|
1.0
|
CD
|
A:PRO168
|
3.7
|
54.9
|
1.0
|
H26
|
A:OW1401
|
3.8
|
42.5
|
1.0
|
H
|
A:GLN192
|
3.9
|
53.8
|
1.0
|
HB2
|
A:GLN192
|
4.0
|
55.8
|
1.0
|
O
|
A:THR190
|
4.1
|
49.9
|
1.0
|
CA
|
A:LEU167
|
4.1
|
41.1
|
1.0
|
O
|
A:GLN192
|
4.1
|
53.4
|
1.0
|
H28
|
A:OW1401
|
4.2
|
40.6
|
1.0
|
HE3
|
A:MET165
|
4.2
|
62.5
|
1.0
|
N
|
A:PRO168
|
4.2
|
48.6
|
1.0
|
CG
|
A:PRO168
|
4.2
|
53.7
|
1.0
|
HD12
|
A:LEU167
|
4.3
|
53.4
|
1.0
|
C15
|
A:OW1401
|
4.3
|
39.5
|
1.0
|
CD1
|
A:LEU167
|
4.3
|
44.5
|
1.0
|
C
|
A:LEU167
|
4.4
|
41.8
|
1.0
|
HD2
|
A:PRO168
|
4.4
|
65.9
|
1.0
|
C
|
A:GLU166
|
4.4
|
38.2
|
1.0
|
HE2
|
A:MET165
|
4.4
|
62.5
|
1.0
|
H19
|
A:OW1401
|
4.6
|
47.5
|
1.0
|
N
|
A:GLN192
|
4.7
|
44.8
|
1.0
|
C20
|
A:OW1401
|
4.7
|
35.4
|
1.0
|
CE
|
A:MET165
|
4.7
|
52.0
|
1.0
|
N
|
A:LEU167
|
4.7
|
38.4
|
1.0
|
HG2
|
A:PRO168
|
4.8
|
64.5
|
1.0
|
CB
|
A:GLN192
|
4.9
|
46.4
|
1.0
|
HA
|
A:PRO168
|
4.9
|
63.0
|
1.0
|
HD11
|
A:LEU167
|
4.9
|
53.4
|
1.0
|
C18
|
A:OW1401
|
4.9
|
30.6
|
1.0
|
C
|
A:GLN192
|
5.0
|
55.0
|
1.0
|
|
Reference:
C.Ngo,
W.Fried,
S.Aliyari,
J.Feng,
C.Qin,
S.Zhang,
H.Yang,
J.Shanaa,
P.Feng,
G.Cheng,
X.S.Chen,
C.Zhang.
Alkyne As A Latent Warhead to Covalently Target Sars-Cov-2 Main Protease. J.Med.Chem. 2023.
ISSN: ISSN 0022-2623
PubMed: 37595260
DOI: 10.1021/ACS.JMEDCHEM.3C00810
Page generated: Fri Aug 2 19:32:54 2024
|